Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001654954-17-003845
Filing Date
2017-05-01
Accepted
2017-05-01 16:50:53
Documents
3
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K mdit10ka_may12017.htm 10-K/A 275135
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-3.htm EX-31.3 18625
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-4.htm EX-31.4 18928
  Complete submission text file 0001654954-17-003845.txt   314029
Mailing Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610
Business Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610 4078490290
Medite Cancer Diagnostics, Inc. (Filer) CIK: 0000075439 (see all company filings)

EIN.: 364296006 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-00935 | Film No.: 17801516
SIC: 3841 Surgical & Medical Instruments & Apparatus